Electroconvulsive therapy: why it is still controversial
Intended for healthcare professionals
Art & Science Previous     Next

Electroconvulsive therapy: why it is still controversial

Tomasz Cyrzyk Registered nurse, Greenwich Hospital, Sydney, Australia

Tomasz Cyrzyk looks at how this intervention came to be used to treat patients with severe mental illness, and why it still divides opinion

Electroconvulsive therapy (ECT) is used in modern psychiatry worldwide, but is not fully understood by the general public, practitioners and researchers. Controversy continues to surround its application, the long-term consequences of its use and its legality in the management of the most serious mental illnesses, such as major depression, bipolar disorder and schizophrenia.

After describing the historical roots of ECT, the author provides a description of the main factors that divide opinion on its use today. This appreciation of the different perspectives, and comparison between attitudes in New South Wales, Australia, and in the UK, can inform the debate about this treatment.

Mental Health Practice. 16, 7, 22-27. doi: 10.7748/mhp2013.04.16.7.22.e769

Correspondence

homecoming@poczta.onet.pl

Conflict of interest

None declared

Peer review

This article has been subject to double blind peer review

Received: 03 November 2011

Accepted: 25 May 2012

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more